Evidence review
Ozempic vs. Wegovy, Mounjaro vs. Zepbound: Same Drug, Different Brand
Ozempic and Wegovy are the same molecule; so are Mounjaro and Zepbound. Here's exactly what differs — indication, dose, and why it matters for you.
Four brand names, two molecules — and the confusion is understandable, because the pairs really are the same active drug marketed two different ways. Here's exactly what's identical, what's different, and why it actually matters which one your provider prescribes.
Semaglutide: Ozempic and Wegovy are the same molecule
Ozempic and Wegovy both contain semaglutide, made by the same manufacturer, Novo Nordisk. The difference is the approved indication and, correspondingly, the labeled dose. Ozempic is approved to improve glycemic control in adults with type 2 diabetes, to reduce cardiovascular risk in adults with type 2 diabetes and established heart disease, and to reduce the risk of kidney disease progression in adults with type 2 diabetes and chronic kidney disease — it is not FDA-approved for weight loss1. Wegovy is approved specifically for chronic weight management in adults and adolescents with obesity, for adults with overweight plus a weight-related condition, to reduce cardiovascular risk in adults with established heart disease and obesity or overweight, and — as of a newer indication — to treat a form of fatty liver disease called MASH2. Wegovy's approved maintenance dose (2.4 mg) is also higher than Ozempic's standard doses, reflecting its weight-management indication21. In practice, this is why some people report a doctor prescribing Ozempic "off-label" for weight loss — it's the identical drug, just approved and dosed for a different primary purpose.
Tirzepatide: Mounjaro and Zepbound are the same molecule
The same pattern holds for Eli Lilly's tirzepatide. Mounjaro is approved to improve glycemic control in adults and adolescents 10 and older with type 2 diabetes, and is not FDA-approved for weight loss3. Zepbound is approved for chronic weight management in adults with obesity or overweight plus a weight-related condition, and — a newer indication — to treat moderate to severe obstructive sleep apnea in adults with obesity4. As with semaglutide, this is genuinely one molecule sold under two names for two approved purposes, and dose ranges are labeled the same way (up to 15 mg maintenance) across both34.
Why the distinction actually matters
Three practical reasons this isn't just brand trivia. First, insurance: a plan is far more likely to cover Ozempic for a diabetes diagnosis than Wegovy for weight loss alone, which is a major reason some people end up on the "diabetes" brand of the molecule they actually want for weight management — see our insurance coverage guide for how that plays out. Second, indication-specific safety data: Wegovy and Zepbound each carry an FDA-approved indication (cardiovascular risk reduction, sleep apnea, MASH) that was proven in trials run specifically on that brand's use case, not automatically assumed from the diabetes drug's data. Third, and most relevant if you're using a telehealth or compounded provider: neither the brand confusion nor the manufacturer's marketing changes what the underlying molecule does — see our semaglutide vs. tirzepatide comparison for how the two molecules actually differ from each other in trial results, side effects, and cost.
Where compounded fits in
Compounded pharmacies prepare semaglutide or tirzepatide directly rather than dispensing a manufacturer's finished pen, so the Ozempic/Wegovy or Mounjaro/Zepbound brand distinction doesn't apply to what you receive — you're getting the molecule itself, not a specific FDA-approved product, indication label, or dose form. That has real trade-offs worth understanding before you compare pricing; see compounded vs. brand-name GLP-1 and is compounded GLP-1 legit and safe.
The takeaway
If a provider or a plan tells you "no" to Wegovy or Zepbound but "yes" to Ozempic or Mounjaro, ask directly why, and know that pharmacologically it's the identical active drug — the difference is the FDA-reviewed indication, the labeled dose, and often the price and coverage attached to that indication. Knowing which brand (or compounded equivalent) you're actually being offered, and why, is core to comparing providers honestly — something our quiz and comparison hub are built to make transparent rather than confusing.
Frequently asked questions
Are Ozempic and Wegovy the same drug?
Yes — both contain semaglutide from the same manufacturer, Novo Nordisk. Ozempic is approved for type 2 diabetes (and related cardiovascular/kidney risk reduction); Wegovy is approved for chronic weight management, cardiovascular risk reduction in obesity, and MASH. The molecule is identical; the approved use and labeled dose differ.
Are Mounjaro and Zepbound the same drug?
Yes — both contain tirzepatide from Eli Lilly. Mounjaro is approved only for type 2 diabetes. Zepbound is approved for chronic weight management and, as a newer indication, for moderate to severe obstructive sleep apnea in adults with obesity.
Why would a doctor prescribe Ozempic instead of Wegovy for weight loss?
Usually insurance: plans are more likely to cover Ozempic under a type 2 diabetes diagnosis than Wegovy under a weight-loss-only diagnosis, so some clinicians prescribe the diabetes-branded version off-label for weight management. Pharmacologically it's the same drug.
Does the brand matter if I get compounded semaglutide or tirzepatide?
The Ozempic/Wegovy or Mounjaro/Zepbound distinction is a manufacturer branding and FDA-indication difference, not a different molecule — so it doesn't apply the same way to compounded medication, which delivers the active drug itself rather than a specific finished, FDA-approved product.
References
- U.S. Food and Drug Administration (2026). Ozempic (semaglutide) injection — Prescribing Information (label). FDA / DailyMed (National Library of Medicine). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79
- U.S. Food and Drug Administration (2026). Wegovy (semaglutide) injection — Prescribing Information (label). FDA / DailyMed (National Library of Medicine). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
- U.S. Food and Drug Administration (2026). Mounjaro (tirzepatide) injection — Prescribing Information (label). FDA / DailyMed (National Library of Medicine). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0
- U.S. Food and Drug Administration (2026). Zepbound (tirzepatide) injection — Prescribing Information (label). FDA / DailyMed (National Library of Medicine). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Continue reading
How to Choose a GLP-1 Provider That Fits You
A friendly checklist for picking a GLP-1 telehealth provider — budget, formulary, speed, support and coverage — plus how our quiz matches you.
ReadCompounded vs. Brand-Name GLP-1s: What the Evidence Actually Shows
FDA approval status, the 503A/503B pharmacy split, the shortage resolution, safety, and cost — an honest, sourced look at compounded vs brand GLP-1s.
ReadSemaglutide vs. Tirzepatide: Head-to-Head on Weight Loss, Side Effects, and Cost
Mechanism, the pivotal STEP and SURMOUNT trials, the head-to-head data, tolerability, and real telehealth pricing — an honest semaglutide vs tirzepatide guide.
ReadBest GLP-1 Provider by Need: Budget, Oral, Fast Start, or Nationwide
The best GLP-1 provider depends on your need. Our picks for budget, oral options, fast starts, and nationwide access — matched to what you want.
ReadInjections vs Oral or Sublingual GLP-1: Which to Pick
Injectable GLP-1s have the big trials behind them; oral and sublingual options trade some evidence for convenience. A measured guide to picking your format.
ReadIs Compounded GLP-1 Legit and Safe?
A measured look at compounded GLP-1: what 503A and 503B pharmacies are, how LegitScript and the FDA fit in, and how to vet a provider.
ReadBest GLP-1 Provider for Long-Term Use: What Maintenance Evidence Says
GLP-1s work as long as you stay on them. Here's what the maintenance trials show, and how to pick a provider you won't outgrow in year two.
ReadHow Much Does Semaglutide Cost Without Insurance? (2026 Telehealth Pricing)
Brand Wegovy cash price vs. compounded telehealth pricing, what's included, plan-length discounts, and HSA/FSA — real 2026 semaglutide pricing.
ReadDo GLP-1s Cause Muscle Loss? What the Evidence Says (and How to Protect Lean Mass)
GLP-1 weight loss includes some lean mass — here's what the trial data actually shows, why it happens, and how protein and resistance training protect muscle.
ReadGLP-1 Side Effects and How to Manage Them (Nausea, GI, and Red Flags)
What semaglutide and tirzepatide side effects feel like, when they hit, how to blunt nausea and GI upset, and the red-flag symptoms that need a clinician.
ReadGLP-1 Dosing & Titration Schedule: Semaglutide and Tirzepatide Step-Up Charts
The standard semaglutide (Wegovy) and tirzepatide (Zepbound) titration schedules, why the slow step-up matters, maintenance doses, and missed-dose guidance.
ReadDoes Insurance Cover GLP-1 Weight-Loss Drugs? (2026 Coverage Reality)
The real state of GLP-1 coverage in 2026: commercial plans, Medicare's weight-loss exclusion, Medicaid, prior authorization, and why so many people pay cash.
ReadHow Much Does Tirzepatide Cost Without Insurance? (2026 Telehealth Pricing)
Brand Zepbound self-pay price vs. compounded tirzepatide telehealth pricing, what's included, and HSA/FSA — real 2026 tirzepatide costs without insurance.
ReadWhat Happens When You Stop Taking a GLP-1? (Weight Regain & How to Come Off)
The evidence on weight regain after stopping semaglutide or tirzepatide, why it happens, and how to taper and build a maintenance plan that holds.
Read"GLP-1 Face": Why Rapid Weight Loss Changes Your Face, and What Helps
What dermatology research actually shows about "Ozempic face" — the facial volume loss from rapid weight loss — why it happens, and what helps.
ReadGLP-1 Injection Guide: Sites, Technique, and Pen Instructions by Brand
Where to inject Ozempic, Wegovy, Mounjaro, or Zepbound, how to rotate sites, and pen technique — straight from each drug's current FDA label.
ReadDoes GLP-1 Medication Cause Hair Loss? What the Evidence Shows
Ozempic, Wegovy, Mounjaro, and Zepbound are all linked to hair shedding — here's what the dermatology research actually says, and when it grows back.
ReadGLP-1 Medication and Alcohol: Drinking, Cravings, and What the Research Shows
Can you drink on a GLP-1? What the trial evidence actually shows about alcohol tolerance, cravings, and why researchers are now testing these drugs for AUD.
ReadGLP-1 Weight-Loss Plateau: Why It Happens and What Actually Helps
Why weight loss on semaglutide or tirzepatide slows or stalls — the physiology behind a plateau, what the trial data shows, and what actually helps.
ReadGLP-1s vs. Older Weight-Loss Pills: Phentermine, Contrave, and Qsymia Compared
How semaglutide and tirzepatide actually compare to phentermine, phentermine-topiramate (Qsymia), naltrexone-bupropion (Contrave), and orlistat.
ReadGLP-1 and Sleep Apnea: What the Zepbound OSA Trial Found
Zepbound is FDA-approved to treat obstructive sleep apnea. Here's what the SURMOUNT-OSA trial actually found, and what it means for treatment and coverage.
ReadGLP-1s and Heart Health: What the SELECT Trial Means for You
Wegovy is FDA-approved to reduce cardiovascular risk, not just body weight. Here's what the landmark SELECT trial found and why it matters for coverage.
ReadGLP-1 Medication and Pregnancy, Breastfeeding, and Birth Control
What the Wegovy and Zepbound labels actually say about pregnancy timing, breastfeeding, and a real interaction with oral birth control — sourced, not guessed.
ReadGLP-1 Medication for PCOS: What the Evidence Shows
PCOS isn't an FDA-approved GLP-1 indication, but real trial evidence supports its use for weight loss and hormonal regulation. Here's what's actually proven.
Read